19
Zevra Therapeutics, based in U.S.A, is a pharmaceutical company.
One of their notable products is ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE, with a corresponding application number 208653 and regulatory information .
proudly manufactured in the
approval since 2019-01-04
Zevra Therapeutics's APADAZ TABLET;ORAL, medication with 325MG;EQ 8.16MG BASE of ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE.
18
Zevra Therapeutics, based in U.S.A, is a pharmaceutical company.
One of their notable products is ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE, with a corresponding application number 208653 and regulatory information .
proudly manufactured in the
approval since 2018-02-23
Zevra Therapeutics's APADAZ TABLET;ORAL, medication with 325MG;EQ 6.12MG BASE of ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE.
17
Zevra Therapeutics, based in U.S.A, is a pharmaceutical company.
One of their notable products is ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE, with a corresponding application number 208653 and regulatory information .
proudly manufactured in the
approval since 2019-01-04
Zevra Therapeutics's APADAZ TABLET;ORAL, medication with 325MG;EQ 4.08MG BASE of ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE.